SCHEMBL5956366

SCHEMBL5956366

Cc1cccc(-c2sc(N)nc2-c2ccnc(-c3ccc(OCC(=O)N4CCOCC4)cc3)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 9/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 2/20 0.47
USP2 O75604 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.43
POLB P06746 1/20 0.43
ALOX5 P09917 1/20 0.42
LMNA P02545 3/20 0.42
MAPK1 P28482 3/20 0.42
GAA P10253 2/20 0.42
MAPT P10636 2/20 0.42
PTBP1 P26599 1/20 0.42
KDM4E B2RXH2 3/20 0.40
HTT P42858 2/20 0.40
PTGS2 P35354 1/20 0.40
TGFBR1 P36897 1/20 0.40
MAPK14 Q16539 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PFKFB3 Q16875 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5956861 0.86 HPGD (0.51) HPGDTGFBR1MAPK14
SCHEMBL5956506 0.85 TGFBR1 (0.46) ALDH1A1LMNAMAPK1MAPTTGFBR1
SCHEMBL5907464 0.83 FKBP1A (0.49) FKBP1AALDH1A1HPGDUSP2SMN1; SMN2
SCHEMBL5956473 0.82 TGFBR1 (0.48) ALDH1A1SMN1; SMN2LMNAGAAMAPT
SCHEMBL5956435 0.81 TGFBR1 (0.48) TGFBR1MAPK14
SCHEMBL5956656 0.79 PRKAB2 (0.49) TGFBR1MAPK14
SCHEMBL5956501 0.78 TGFBR1 (0.56) TGFBR1MAPK14
SCHEMBL5956423 0.76 TGFBR1 (0.66) MAPK1TGFBR1MAPK14
SCHEMBL5956486 0.76 TGFBR1 (0.57) ALDH1A1SMN1; SMN2LMNAGAAMAPT
SCHEMBL5907494 0.76 FKBP1A (0.52) FKBP1AALDH1A1HPGDUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060004051-A1 Compounds DODIC NERINA 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060004051-A1 Compounds SMAD3, SMAD2, TGFBR1 FKBP1A 1404/4885ALDH1A1 3030/4885HPGD 4433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.